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Purpose: Median nerve somatosensory evoked responses 
(MnSSER) alterations were compared to clinical tests (cold 
and pinprick) variations, in 20 ASA I adult patients following 
infraclavicular block obtained with 40 mL ropivacaine 0.5% 
to assess first, the difference of time course of the respective 
electrophysiological and clinical signs, and second, the objectiv-
ity and the reproducibility of MnSSER changes.
Clinical features: Four MnSSER derivations (Erb’s point; cuta-
neous projection of peripheral end of brachial plexus; posterior 
neck at C6 level, frontal and controlateral parietal scalp) were 
monitored and recorded for retrospective analysis. Continuous 
data acquisition were started before ropivacaine injection 
(baseline) and maintained for 30 min thereafter. Every three 
minutes after ropivacaine injection, cold and pinprick tests were 
performed in the hand median nerve cutaneous supply zone 
and were assessed using a sensory visual score (varying from 
0–10). Data were compared using analysis of variance. Although 
MnSSER values were stable during baseline period, after ropiva-
caine administration, severe progressive amplitude depressions 
of selected MnSSER were detected in every patient. While 
clinical cold and pinprick tests became positive (score > 8) only 
15.8 ± 1.2 min and 20.1 ± 1.8 min respectively after ropiva-
caine administration, the mean time to observe the earliest 
MnSSER 20% amplitude decrease at Erb’s point derivation was 
reduced to 5.6 ± 1.1 min (P < 0.01).
Conclusion: Selected MnSSER amplitude reduction indicates 
objectively the onset of median nerve anesthesia following 
infraclavicular brachial plexus block before the appearance of 
clinical signs.
Objectif : Les modifications des potentiels évoqués somesthésiques 
du nerf médian (PESNM) induit par un block infraclaviculaire (40 
mL de ropivacaine 0,5 %) on été comparés avec les tests cliniques 
usuels (tests au froid et à la piqûre) chez 20 patients adultes ASA 
I afin d’évaluer la différence d’évolution et de survenue des signes 
électrophysiologiques et cliniques, l’objectivité et la reproductibilité 
des modifications des PESNM et finalement le possible intérêt en 
pratique clinique.
Eléments cliniques : Les PESMN étaient enregistrés en continu 
au point d’Erb (projection cutanée de l’extrémité latérale du plexus 
brachial) et successivement au niveau cervical en regard de la six-
ième vertèbre), frontal et pariétal controlatéral pour une comparai-
son secondaire. L’enregistrement a commencé avant l’injection de 
ropivacaine et jusqu’à 30 min après. Toutes les trois minutes après 
la réalisation du bloc, les tests cliniques étaient réalisés au niveau 
de la main d’innervation du nerf médian en utilisant une échelle 
visuelle analogique (0–10). Une analyse de variance a été utilisée 
pour comparer les résultats. Si les PESNM étaient remarquable-
ment stables avant la réalisation du bloc, après leur amplitude 
diminue précocement et de façon importante, chez tous les sujets. 
Alors que les tests au froid et à la piqûre peuvent être considérés 
comme positifs (> 8 sur l’échelle) seulement après 15,8 ± 1,2 min 
et 20,1 ± 1,8 min respectivement après l’injection de ropivacaïne, 
la diminution la plus précocement détectable de l’amplitude du 
potentiel (20 %) au point d’Erb, survenait en moyenne en 5,6 ± 
1,1 min (P < 0,01).
Conclusion : La diminution de l’amplitude des PESNM indique 
objectivement la survenue du bloc du nerf médian après la réalisa-
tion d’un bloc infraclaviculaire avant toute modification clinique.
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C
LINICAL assessment of the onset and 
extent of sensory block during regional 
anesthesia can be a challenging task. The 
problem of subjectivity in both percep-
tion and expression of sensory block is unresolved, 
justifying the proposal of an “ideal multimodal test-
ing sequence” based on recently compiled methods.1 
Swelling illusion2 can be an alternative, but unfortu-
nately is sometimes difficult to understand by some 
patients. Somatosensory evoked potential (SSEP) 
monitoring either for peripheral nerve block3–6 and iv 
regional anesthesia7 or for epidural anesthesia8 has the 
potential to provide an objective assessment of nerve 
block. Nevertheless, preliminary results cannot neces-
sarily be extrapolated to clinical practice. Our study 
was thus designed: first, to describe the effect of ropi-
vacaine, on the brachial plexus using the infraclavicu-
lar approach, guided by median nerve somatosensory 
evoked responses (MnSSER) and second, to monitor 
clinically the sensory visual analogue score (SVAS) 
variations2 in response to cold and pinprick tests 
applied in the hand’s median nerve cutaneous supply 
zone. We postulated that the median nerve blockade 
onset in the brachial plexus can be anticipated by 
quantitative variations of MnSSER recordings. 
Material and method
Patient selection 
After giving written informed consent, nine males 
and 11 females non obese patients (18–42 yr old, 
ASA class I), were enrolled in this study approved by 
the Local Authors Institutional Human Investigation 
Committee (Erasmus Hospital in Brussels, Belgium). 
After alprazolam 0.5 mg po given one hour before 
anesthesia, no other sedative or analgesic drug was 
used before, during or after the block initiation until 
study completion.
Median nerve somatosensory evoked response recordings
Before baseline and for 30 min after the ropivacaine 
administration, the median nerve was stimulated at the 
wrist (frequency 1 Hz and duration 0.2 msec) using 
the electrical stimulator of an Epoch 2000™ (Axon 
Systems Inc, San Francisco, CA, USA). The stimula-
tion intensity was decreased by 2 mA when the evoked 
muscular twitches were observed (between 12 and 17 
mA). Somatosensory evoked responses were recorded 
from sc needle electrodes at Erb’s point (cutaneous 
projection of the peripheral end of the brachial plexus 
2–3 cm above the clavicle), designated as “Erb”; from 
the cervical spine (just above the cutaneous projection 
of the spinous process of the sixth cervical vertebrae) 
designated as “C6” - and at the scalp, at the median 
prefrontal level (Fpz)- designated as “Fpz” and at the 
contralateral parietal level (P’4) - designated as “P’4”. 
A common reference electrode (positive pole) was 
positioned on the ipsilateral ear designated as “A”. All 
electrode impedances were automatically checked for 
values less than 5 kOhms. The recording frequency 
bandpass was 30 to 750 Hz and the sampling window 
50 msec. Artifact rejection threshold was fixed at 25 
µV. The 50 Hz notch filter was active.
Median nerve somatosensory evoked responses data 
acquisition methodology 
Monitored MnSSER were respectively: P10, a peak 
present 10 ± 0.5 msec after stimulation, in A-Erb 
derivation; P11, at 11 ± 0.5 msec in the A-C6 deriva-
tion; N20, at 20 ± 0.5 msec in the controlateral A-P’4 
derivation and P22, at 22 ± 0.5 msec in the A-Fpz 
derivation. Before acquisition of baseline measure-
ments, three groups of 500 averaged responses were 
required to assess a good visual reproducibility of 
evoked potential recordings. Triplicate MnSSER base-
line measurement acquisitions were then performed 
approximatively five minutes prior to the ropivacaine 
injection. The average of the amplitude and latency 
values obtained (labelled “t-5”) were used as refer-
ence for subsequent comparison. Immediately after 
the ropivacaine injection (labelled “t0”) and during 
the next 30 min, the averaging technique was applied 
continuously to obtain the MnSSER responses every 
100 sweeps (MnSSER every 15–20 sec). The pre- and 
post-ropivacaine administration previously defined 
signals were automatically saved for retrospective 
analysis from each recording site. Besides manual 
retrospective analysis, the automatic tracker software 
of our monitoring system was able to detect, from 
baseline values, a 20% variation either in amplitude or 
in latency, widely accepted as the correct threshold for 
significant changes. The maximal electrophysiological 
effect, based on a non-automated analysis by a blinded 
observer, was defined as an evoked response amplitude 
of less than 0.5 µV present in three successive averag-
ing periods.
Infraclavicular brachial plexus block
The infraclavicular block was performed following the 
Raj’s approach.9 After local anesthesia, a 10-cm long, 
short bevel insulated needle (Stimuplex ATM, BBraun 
Inc., Melsungen, Germany) connected to the nega-
tive pole of a nerve stimulator (Stimuplex HNS11TM 
BBraun Inc., Melsungen, Germany - 100 µsec pulse 
width, 1.5 mA initial current intensity at 1 Hz), 
was inserted. After median nerve location (muscular 
twitches corresponding to wrist, second and third 
68 CANADIAN JOURNAL OF ANESTHESIA
finger flexion and forearm pronation), with a minimal 
stimulation current intensity of 0.5 mA, 40 mL of 
ropivacaine 0.5% were injected.
Clinical assessment of sensory blockade
After ropivacaine administration, cold and pinprick 
tests were performed every three minutes to assess 
anesthesia on the palmar face of the base of the sec-
ond and third fingers (median nerve cutaneous supply 
zone). The patient documented his/her perceptions 
according to a SVAS, similarly to the Benzon’s meth-
od.3 The scale consisted of a 10-cm line, where the 0 
cm mark stated “my cutaneous zone is not numbed 
at all”, while 10 cm corresponded to “my cutaneous 
zone is completely numbed”; scores less than 1 were 
matched as a “no block” whereas those higher than 
8 as “a good and effective block”. The latter score 
was considered adequate for quatifying the clinical 
effectiveness of the block. Following cold or pinprick 
stimulation, we obtained cold SVAS (cSVAS) or pin-
prick SVAS (pSVAS), respectively. 
Data analysis
Mean values of amplitude and latency of each MnSSER 
(P10, P11, N20 and P22) at time t-5 where considered 
as baseline values. The MnSSER waves, registered 
before and immediately after each SVAS clinical assess-
ment performed every three minutes from t0 to t30, 
were extracted from the raw data and averaged. The 
parameters produced every three minutes after ropi-
vacaine administration therefore consisted of mean 
MnSSER amplitudes and latencies, cSVAS and pSVAS 
values. 
For statistical analysis, one way and repeated mea-
sures ANOVA tests were used (Instat 3.05TM and 
Prism 3.03 TM softwares - Graph Pad Software Inc, 
San Diego, CA, USA). 
The analysis permitted: 1) evaluation of individual 
stability and reproducibility of the baseline MnSSER 
by comparison of the respective amplitudes and laten-
cies of baseline evoked potentials from the three initial 
averages of 500 sweeps to confirm the initial on-line 
visual inspection of the profiles of the different waves; 
2) testing the existence or not of a possible bias 
induced by the physical effect of the 40 mL anesthesia 
solution injection, by comparing the mean amplitudes 
and latencies of each monitored MnSSER at baseline 
and t0 (just after the injection) and; 3) the time evolu-
tion of amplitude and latency of each MnSSER and 
the two SVAS scores. The results are presented as 
mean ± SD. A P value < 0.05 was considered statisti-
cally significant. 
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TABLE I  Somatosensory evoked responses before and after ropivacaine
 Baseline records   Ropivacaine injection
 “Reproducibility of baseline MnSSERs”  “Local physical effect of ropivacaine”
 Baseline Baseline Baseline One way t-5 t0 One Way
 Run (1) Run (2) Run (3) ANOVA   ANOVA
Mean amplitudes (µV)
P10 4.1 ± 0.8 3.9 ± 0.9 4.2 ± 0.7 P = 0.49 4.1 ± 0.6 4.3 ± 0.7 P = 0.68
P11 1.6 ± 0.7 1.4 ± 0.6 1.7 ± 0.5 P = 0.49 1.5 ± 0.5 1.3 ± 0.5 P = 0.51
N20 2.9 ± 0.7 2.9 ± 0.6 3.1 ± 0.4 P = 0.46 2.9 ± 0.3 2.7 ± 0.5 P = 0.57
P22 2.1 ± 0.6 2.1 ± 0.7 1.9 ± 0.6 P = 0.52 2.0 ± 0.8 2.1 ± 0.5 P = 0.66
Mean latencies (msec) 
P10 9.7 ± 0.7 10.2 ± 0.8 10.1 ± 0.6 P = 0.68 10.1 ± 0.6 10.3 ± 0.4 P = 0.69
P11 11.3 ± 0.4 11.1 ± 0.8 10.9 ± 0.7 P = 0.56 11.1 ± 0.7 11 ± 0.5 P = 0.71
N20 20.1 ± 0.8 20.2 ± 0.7 19.8 ± 0.8 P = 0.53 20.1 ± 0.6 20.3 ± 0.9 P = 0.59
P22 21.9 ± 0.7 22.3 ± 0.6 22.1 ± 0.7 P = 0.47 22.1 ± 0.8 22.2 ± 0.6 P = 0.68
Median nerve somatosensory evoked responses (MnSSERs) during baseline records (four columns on right including ANOVA compari-
son) and before and after the ropivacaine injection (three columns on left including ANOVA comparison). Results are expressed as mean 
values ± standard deviation. For the baseline records, mean amplitude and latency values of each MnSSER have been calculated from the 
respective 20 individual values. The statisqtical comparison of these averages relates the stability and the reproducibility of these evoked 
potentials. For the ropivacaine injection physical effect, the mean amplitudes and latencies of the respective waves prior to the injection (t-
5) correspond to the average of the three successive baseline mean values (baseline run 1–3). They have been considered as baseline values 
for further comparison. Just after the ropivacaine injection (t0), mean amplitudes and latencies have been calculated from the respective 20 
individual values at t0. The statistical comparison between t-5 and t0 demonstrates the lack of local physical effect of the ropivacaine solu-
tion on the MnSSER recordings.
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Results
Regional anesthesia procedure
Infraclavicular block was successfully performed in 
all 20 patients by five different anesthesiologists. The 
neural blockade obtained was effective in the median 
nerve supply, as well as regions of the ulnar and the 
radial nerves, allowing the scheduled surgery. The 
mean infraclavicular block duration was 6.2 ± 0.6 min 
(time elapsed between local anesthesia and end of the 
ropivacaine injection). During the study period, the 
plexus block failed to occur (no median nerve block) 
in three patients from the 20 included, in spite of 
the correct median nerve stimulation. In these three 
patients, no changes were recorded. Our comparison 
between electrophysiological and clinical assessment of 
the nerve block was based only on successful blocks.
Electrophysiological signal variations
The mean time to install the MnSSER equipment set 
and electrode insertion was 5.3 ± 0.4 min.
Values and reproducibility of baseline measurements
Before ropivacaine administration, mean MnSSER 
amplitudes and latencies recorded in three consecutive 
runs were stable (one-way ANOVA; NS) and docu-
mented normal baseline numerical values (Table I).
Lack of immediate physical effects of 40 mL ropiva-
caine administration 
Comparison of mean amplitude and latency values of 
P10, P11, N20 and P22 before and just after anes-
thetic solution injection did not demonstrate any dif-
ference (Table I) whatever the MnSSER considered 
(one way ANOVA, NS).
FIGURE 1  Changes of median nerve somatosensory 
evoked responses (MnSSER; P10, P11, N20, P22) ampli-
tudes (black squares) and latencies (black triangles) over 
time. The successive amplitude values of each MnSSER 
were compared to the respective initial one (baseline) using 
one way ANOVA (*P < 0.05). The number of patients with 
recordable amplitude signal (> 0.5 µV) is indicated in the 
rectangular area located at the bottom of each figure.
TABLE II  Sensory visual analogue scores
 Delays (min) One way ANOVA
P10 5.6 ± 1.1 -
P11 5.8 ± 1.3 P = 0.60
N20 7.6 ± 1.3 P = 0.021
P22 8.4 ± 1.4 P = 0.026
cSVAS 15.8 ± 1.2 P = 0.0081
pSVAS 20.1 ± 1.8 P = 0.0093
SVAS = sensory visual analogue scale. Mean delays for the record-
ing of a detectable and readable automatic 20% amplitude decrease 
for P10, P11, N20, P22 and the observation of equal or greater 
than 8 cSVAS and pSVAS (left column; results are presented as 
mean value ± SD). For statistical analysis (right column), the dif-
ferent delays observed were all compared to the delay observed for 
P10.
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Median nerve somatosensory evoked responses amplitude 
and latency evolution after ropivacaine administration 
Figure 1 depicts the evolution of mean amplitude 
and latency of the MnSSER over the time from base-
line (t-5) until 30 min after local anesthetic injection. 
Independently from the MnSSER, mean amplitudes 
have decreased progressively and significantly until 
they became very often undetectable. A significant 
reduction in peripheral MnSSER (P10 and P11) was 
observed faster than in central ones (N20 and P22 - 
Table II and Figure 1). Table II summarizes the time 
elapsed after ropivacaine administration and the stan-
dard 20% amplitude decrease observed at P10, P11, 
N20 and P22. N20 and P22 alteration times were 
different compared to the P10 delay (P = 0.021 and P 
= 0.026, one way ANOVA, respectively).
Sensory visual analogic score and clinical block
Assessment of the mean time elapsed for confirming 
the clinical signs of a valuable median nerve block (cor-
responding to a cSVAS or a pSVAS score ≥ 8) showed 
mean delays of 15.8 ± 1.2 min for cold and after 20.1 
± 1.8 min for pinprick tests (Table II and Figure 2). 
Comparison between MnSSER and SVAS
The differences between the delays documented 
with MnSSER recordings and the clinical criteria for 
establishment of median nerve block are presented in 
Table II (for comparison between P10 and cSVAS 
or a pSVAS). A difference of about ten minutes was 
observed between the P10 20% decrease time, and 
cSVAS (P = 0.0081, one way ANOVA); for pSVAS, 
the mean supplementary waiting delay increased to 14 
min (P = 0.0093, one way ANOVA).
Discussion
Somatosensory evoked potentials are effective to qual-
ify and/or quantify the occurrence and time course 
of electrophysiological changes associated with neural 
block induced by local anesthetics.3–8 Nevertheless, 
previous studies have not been able to identify direct 
clinical applications. Consequently, the goal of our 
study was to describe the MnSSER alterations indicat-
ing a successful median nerve block of the brachial 
plexus by adapting Benzon’s3 methodology in surgical 
patients. The median nerve was preferred because the 
ease of its location by the infraclavicular approach10 
using a single injection technique, verifying optimal 
position of the needle tip near the brachial plexus.9
Consistent with other published data,3,7 no sig-
nificant changes in the latencies were observed, but 
depression of MnSSER amplitude in the diverse chan-
nels appears as a good indice for detecting the onset 
and the progression of a chemically induced neural 
blockade. In the present context, (quantification 
with a possible anticipation of a potentially successful 
neural blockade), it seems evident that limited ampli-
tude reduction (by 20%) is a good clinical indicator. 
Each time a 20% amplitude reduction is observed, the 
MnSSER will eventually disappear, indicating effective 
median nerve blockade. The 20% value was chosen 
because the default tracking method of our moni-
toring system permitted an automatic detection of 
MnSSER alterations. However, for a human observer, 
the depression of amplitude and its time course can 
be more easily noticed and detected on the periph-
eral MnSSER collected at Erb’s point, as their initial 
amplitudes (3–5 µV) are always higher than the ones 
recorded more centrally (< 2.5–3 µV). On the Erb’s 
point derivation, the detection occurred during the 
early phase (ranging between three to six minutes) of 
the ropivacaine induced block.
An unresolved issue is whether or not SSEP 
assessment of one brachial plexus nerve is sufficient 
to conclude that the plexus block will be complete. 
Based upon our experience, we think “no”. Although 
MnSSER can detect objectively the early occurrence 
of an effective brachial plexus block compared to clini-
cal assessment, the correlation between median nerve 
location and plexus anatomy is variable. Accordingly, 
a more systematic SSEP investigation of median, ulnar 
and radial nerves during brachial plexus block tech-
niques (not only infraclavicular, but also axillary, inter-
scalene and subclavicular) may simplify the technique 
and clarify its usefulness in clinical practice.
FIGURE 2  Time evolution of the cSVAS (white square) 
and pSVAS (white triangle). Lower horizontal dot line 
matches for threshold of clinically absent nerve block (score 
< 1), while the upper one corresponds to the presence of an 
effective block (score > 8).
72 CANADIAN JOURNAL OF ANESTHESIA
In conclusion, MnSSER monitoring in adult 
patients permits objective quantification of the onset 
of clinical median nerve blockade after 40 mL of 0.5% 
ropivacaine for brachial plexus blockade. The P10 
amplitude decrease is always associated with a clini-
cally successful block, and appears about ten minutes 
earlier than the clinical confirmation of median nerve 
block. This electrophysiologically-based, pain-free 
monitoring may be important in clinical anesthesia, 
and provides a method for studying more objectively 
the clinical action of local anesthetic solutions. 
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